KeyCorp Begins Coverage on Addus HomeCare (NASDAQ:ADUS)

KeyCorp began coverage on shares of Addus HomeCare (NASDAQ:ADUS) in a research report sent to investors on Friday, Marketbeat.com reports. The brokerage issued an overweight rating and a $150.00 price objective on the stock.

Several other research analysts have also issued reports on the company. Stephens reaffirmed an overweight rating and set a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an outperform rating in a research report on Monday, September 23rd. StockNews.com lowered Addus HomeCare from a strong-buy rating to a buy rating in a research report on Sunday, July 7th. Royal Bank of Canada reaffirmed an outperform rating and set a $141.00 target price on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Finally, Macquarie started coverage on Addus HomeCare in a research report on Friday, June 28th. They set an outperform rating and a $136.00 target price on the stock. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus price target of $131.38.

Addus HomeCare Trading Up 2.5 %

ADUS opened at $130.63 on Friday. The firm has a market cap of $2.36 billion, a price-to-earnings ratio of 32.41, a PEG ratio of 2.33 and a beta of 1.04. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $136.12. The stock has a fifty day moving average price of $129.54 and a 200-day moving average price of $117.34.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, topping the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million during the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.94 EPS. On average, equities research analysts forecast that Addus HomeCare will post 4.58 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at $429,165. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,917 shares of company stock worth $3,050,082. 4.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Point72 Asset Management L.P. boosted its position in shares of Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares during the period. Millennium Management LLC boosted its holdings in Addus HomeCare by 412.7% in the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after purchasing an additional 254,705 shares during the period. Boston Partners purchased a new position in Addus HomeCare in the first quarter valued at $12,215,000. Ghisallo Capital Management LLC purchased a new position in Addus HomeCare in the second quarter valued at $11,611,000. Finally, Lord Abbett & CO. LLC purchased a new position in Addus HomeCare in the first quarter valued at $8,274,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.